Metabolites and mood in bronchiectasis
Part of Lungs & breathing, Mental health clinical trials.
This study looks at how body chemistry is linked to anxiety and depression in people with bronchiectasis. It may help find new ways to understand and treat mood symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with bronchiectasis (confirmed by a lung scan and symptoms).
- Your condition has been stable for the past 4 weeks (no antibiotics or steroid pills).
- You do not have cystic fibrosis or a history of lung transplant.
- You do not have an active infection like tuberculosis or a serious illness affecting your heart, brain, liver, or kidneys.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how nutrition affects the course of bronchiectasis, a lung condition that causes coughing and frequent infections. It may help find ways to slow the disease down.
This study looks at how bacteria live in the lungs of people with bronchiectasis and how they may adapt over time. It may help researchers understand why infections keep coming back and how to better manage chronic lung colonization.
This study looks at why bronchiectasis gets worse over time. It may help doctors understand the disease better and find better ways to monitor or treat it.
This study looks at the community of tiny organisms in the lungs (the lung microbiome) in people with bronchiectasis caused by NTM (non-tuberculous mycobacteria). It compares people with positive NTM cultures to people without, to better understand what’s going on in the lungs and why symptoms may differ.
This study helps doctors understand how severe your bronchiectasis is and predict when you might have flare-ups. You'll have routine tests over 12 months to help researchers learn more about this condition and improve future care.
This trial tests if a new drug, GSK3862995B, is safe and effective for adults with bronchiectasis. It might help reduce lung infections and improve symptoms.
Hear when a new Bronchiectasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.